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Background: ADAMTS-12 is a metalloprotease of unknown biological function. Mice deficient in Adamts12 show no
obvious phenotype.
Results: Adamts12-deficient mice exhibit increased inflammatory response and reduced neutrophil apoptosis.
Conclusion: This protease is necessary for resolution of inflammation allowing normal neutrophil apoptosis.
Significance: ADAMTS-12 has a role in inflammation, contributing to better understanding of the etiology of inflammatory
diseases.
ADAMTSs (a disintegrin and metalloprotease with throm-
bospondin domains) are a family of enzymes with both proteo-
lytic and protein interaction functions, which have been impli-
cated in distinct pathologies. In this work, we have investigated
the putative role of ADAMTS-12 in inflammation by using a
mouse model deficient in this metalloprotease. Control and
mutant mice were subjected to different experimental condi-
tions to induce colitis, endotoxic sepsis, and pancreatitis. We
have observed that Adamts12-deficient mice exhibit more
severe inflammation and a delayed recovery from these chal-
lenges compared with their wild-type littermates. These
changes are accompanied by an increase in inflammatorymark-
ers including several cytokines, as assessed by microarray
expression analysis and proteomic-based approaches. Interest-
ingly, the clinical symptoms observed in Adamts12-deficient
mice are also concomitant with an elevation in the number of
neutrophils in affected tissues. Finally, isolation and in vitro cul-
ture of human neutrophils demonstrate that the presence of
ADAMTS-12 induces neutrophil apoptosis. On the basis of
these results, we propose that ADAMTS-12 is implicated in
the inflammatory response by modulating normal neutrophil
apoptosis.
Metalloproteases regulate many biological processes in all
living organisms through their ability to specifically cleave pep-
tide bonds in a variety of substrates (1). Among them, the
ADAMTSs4 (a disintegrin andmetalloproteasewith thrombos-
pondin domains) are a family of 19 secreted metalloproteases
showing structural similarities toMMPs (matrixmetalloprotei-
nases) and ADAMs (a disintegrin and metalloprotease) such as
the presence of a zinc-chelating motif essential for the enzy-
matic activity. However, the occurrence of different thrombos-
pondin domains within their architecture represents a dis-
tinctive structural hallmark of ADAMTSs (2, 3). These
thrombospondin domains, togetherwith other ancillarymotifs,
constitute a region that likely acts by modulating substrate
binding, determining cell location or sequestering factors in the
extracellular matrix. Some ADAMTSs, such as ADAMTS-4
and ADAMTS-5, have been related to inflammatory-related
processes including arthritic diseases (4). Therefore, it is tempt-
ing to speculate that the altered function of any of these
ADAMTSs putatively involved in inflammation could contrib-
ute to the development of a variety of human diseases. In this
regard, it is well established that abnormal and persistent
immune responses are responsible for pathologies such as
inflammatory bowel diseases, rheumatoid arthritis, atheroscle-
rosis, or allergies. All of these conditions have increased their
prevalence during the past decades and now constitute a major
concern for public health with limited therapeutic opportuni-
ties (5). There is growing evidence that these pathologies are
caused by a complex interaction between multiple susceptibil-
ity loci and environmental factors. Accordingly, identification
of genes involved in inflammatory diseases and further charac-
terization of their mechanisms of action represent suitable
strategies for future clinical improvement of these conditions.
ADAMTS-12 was first identified and cloned in our labora-
tory in 2001 (6), although little is known concerning its normal
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biological functions. In contrast, there is growing information
about the putative pathological relevance of this enzyme.
ADAMTS-12 has been associated with osteoarthritis due to its
ability to degrade the cartilage components aggrecan and car-
tilage oligomeric matrix protein (7, 8) and has been genetically
related to rheumatoid arthritis (9).Moreover, ADAMTS-12has
been genetically linked to schizophrenia and asthma (10, 11). In
neoplastic diseases, ADAMTS-12 has been described to act as
an anti-tumor protease. In this regard, we have previously
reported that this metalloprotease inhibits pro-tumor activities
of Madin-Darby canine kidney and bovine aortic endothelial
cells as well as in vivo growth of A549 tumor cells in SCIDmice
(7). Furthermore, ADAMTS12 is hypermethylated in tumors
from different origins, and, at least in colorectal cancer, the
epigenetic silencing occurring in tumor cells is compensated by
its overexpression inmyofibroblasts of the surrounding stroma
(12, 13). To try to elucidate the biological roles of this enzyme,
we have recently established a mouse strain lacking Adamts12,
which shows no obvious phenotype but exhibits significant dif-
ferences in cancer susceptibility compared with control mice
(14). Thus, Adamts12-deficient mice are more susceptible to
cancer development, displaying increased angiogenesis and
tumor invasion.
In the present work, we have studied the putative role of
ADAMTS-12 in inflammation. For that purpose, we have
examined the mouse model lacking Adamts12 under distinct
inflammatory conditions including ulcerative colitis, sepsis,
and pancreatitis, with the finding that the absence of this pro-
tease causes increased inflammation. Moreover, we have ana-
lyzed the inflammatory response ofAdamts12-deficient tissues
at the molecular level and observed that several inflammatory
markers are also increased at both RNA and protein levels and
correlate with the observed clinical features. Finally, we have
found that Adamts12-null mice undergo an excessive accumu-
lation of neutrophils due to their reduced apoptosis. On the
basis of these results, we propose that ADAMTS-12 exerts a
protective role in inflammatory pathologies, avoiding a detri-
mental concentration of neutrophils by inducing their appro-
priate apoptosis.
EXPERIMENTAL PROCEDURES
Animals—Adamts12/ mice were generated and geno-
typed as described previously (14). Briefly, exons 6 and 7 were
replaced by a neomycin-phosphoglycerate kinase cassette
through homologous recombination, causing introduction of a
frameshift. The embryonic stem cells generated were then
injected intoC57BL/6J blastocysts. Animalswere housed under
specific pathogen-free conditions; all experiments were carried
out at an age of 8–10 weeks and following the guidelines of the
Committee on Animal Experimentation of the Universidad de
Oviedo, Oviedo, Spain.
Induction of Colitis—27 Adamts12/ and 33 Adamts12/
mice were treated with 2% dextran sulfate sodium salt (DSS;
MPBiomedicals) in drinking water for 7 days, followed by 1 day
of water. Body weight and colitis clinical symptoms were mon-
itored daily. At days 0, 3, 6, and 8, mice were sacrificed, and their
colons were removed, measured, and washed to obtain colonic
lavages. Afterward, colonswere processed for histological analysis
or frozen for protein extraction. An additional group of 14
Adamts12/ and 15 Adamts12/ mice was subjected to the
same protocol to determine mortality rates and to estimate the
degree of affectation at day 16, when initial weight was recovered.
LPS-induced Sepsis Model—36 Adamts12/ and 38
Adamts12/ mice were injected intraperitoneally with 8.5
mg/kg body weight of lipopolysaccharide (LPS; Sigma) in saline
solution. Body weight was monitored daily. At days 2, 3, and 8,
a minimum of 8 mice were anesthetized, and blood samples
were taken by intracardiac puncture. Animals were then sacri-
ficed and liver and spleen removed. Cell population abun-
dances in blood were determined in the hematology analyzer
Abacus Junior Vet (Diatron) and by flow cytometry using a
combination of specific antibodies against murine CD45 (BD
Biosciences 550994), CD45R (552094), and CD3e (553061).
Cerulein-induced Pancreatitis—10 Adamts12/ and 9
Adamts12/ animals were injected intraperitoneally hourly
with 50 g of cerulein (Sigma)/kg of body weight for 10 h.
Untreated controls were treated with saline solution solely.
One hour after the last injection, animals were anesthetized,
and blood was obtained by intracardiac puncture and pancreas
isolated. Serum levels of amylase and lipase were determined
enzymatically in a Cobas 6000 analyzer (Roche Diagnostics).
Analysis of Cytokine Levels in Colonic Lavages—After colon
extraction, 1 ml of PBS was passed three times through the
large intestine. Protein concentration was quantified using
the BCA Protein Assay kit (Pierce), and 30 g of total protein
from each sample was used in subsequent experiments. To
select cytokines showing differences between both genotypes,
we performed a preliminary analysis using the Multi-Analyte
ELISArray (Tebu-bio), and those exhibiting differences were
further analyzed in eight animals per genotype and time point
using ELISAkits for detection of IL-1, IL-6, andG-CSF (Tebu-
bio) following the manufacturer’s instructions.
Histological Analyses andMyeloperoxidase (MPO) Immuno-
histochemistry—Tissue samples were fixed with 4% formalde-
hyde for 24 h, washed with 70% ethanol, and embedded in par-
affin. Sections were stained with hematoxylin and eosin and
analyzed by an expert pathologist. For interacinar septa quan-
tification, we performed six measurements per animal slide
with ImageJ software. The number of polymorphonuclear cells
was determined byMPO immunohistochemical detection. The
reaction was carried out with an anti-MPO antibody (Thermo
Fisher Scientific) in the Discovery XT System (Ventana). First,
unmasking was performed by heating at pH 8.4 with CC1
buffer. Then, slides were blocked with the casein-based anti-
body block and incubatedwith the antibody at 37 °C, for 1 h and
at 1:50 dilution in antibody diluent. The secondary antibody
used was OmniMap anti-rabbit horseradish peroxidase, and
detection was carried out with ChromoMap DAB. Contrast
staining was performed with hematoxylin and bluing reagent
(all reagents from Ventana). After staining, the number of
MPO-positive cells in equivalent areas of ulceration was deter-
mined in slides from Adamts12-proficient and -deficient mice
(6 fields/slide, n 4/group).
RNA Expression Arrays—Whole RNA from colon was iso-
lated using TRIzol (Invitrogen) and purified with the RNeasy
Mini Kit (Qiagen). Concentration and quality of samples were
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determined using an Agilent 2100 Bioanalyzer, and those with
the best quality were selected for hybridization with GeneChip
Mouse Gene 1.0 ST Arrays (Affymetrix), following the manu-
facturer’s instructions. Quality control of microarray data was
performed using Affymetrix Expression Console. Data are
expressed as base 2 exponentials. Array data were deposited at
the Gene Expression Omnibus with the accession number
GSE40529. Bioinformatic analysis was performed using the
Babelomics platform.
Proteomic Studies and MALDI-ToF Analysis—Colons from
Adamts12/ and Adamts12/mice were homogenized in
TUCT (7 M urea, 2 M thiourea, 4% CHAPS, and 30 mM Tris-
HCl, pH 8.5). 50 g of each sample were labeled with 400 pmol
of a specific fluorophore (GE Healthcare): CyDye 3 (WT sam-
ple), CyDye 5 (KO sample), and CyDye 2 (pool of WT and KO
samples 1:1). Labeled samples were combined, and UCDA (8 M
urea, 4%CHAPS, 130mMDTT and 2% isoelectrofocusing (IEF)
buffer) was added in a 1:1 ratio. Then, UCda (8 M urea, 4%
CHAPS, 13mMDTT, and 1% IEF buffer) was added up to 450l
final volume. Samples were loaded in a strip holder, and a
24-cm immobilized pH gradient (IPG) strip, pH gradient 3–11
nonlinear (GE Healthcare), was placed over it. IEF was per-
formed for 26 h at a gradient voltage on an IPGphor Unit (GE
Healthcare). Then, the strip was equilibrated in SES-DTT (6 M
urea, 30% glycerol, 2% SDS, 75mMTris-HCl, pH 6.8, 0.5%DTT,
and bromphenol blue), and in SES-IA (6 M urea, 30% glycerol,
2% SDS, 75 mM Tris-HCl, pH 6.8, 4.5% iodoacetamide, and
bromphenol blue) and mounted on top of a 13% SDS-PAGE in
a Hoefer S600 device (Ettan DALT Six; GE Healthcare). After
SDS-PAGE, CyDye-labeled proteins were visualized directly by
scanning using a TyphoonTM 9400 imager (GE Healthcare).
The excitation laser wavelengths were 488 nm for Cy2, 532 for
Cy3, and 633 for Cy5. The emission filters employed were of
520 nm band pass 40, 580 nm band pass 30, and 670 nm band
pass 30, respectively. The gel was scanned, analyzed with Pro-
genesis SameSpots software (NonLinear Dynamics), and
stained with SYPRO Ruby (Invitrogen). Differential spots were
excised, washed with 25 mM ammonium bicarbonate/acetoni-
trile (70:30), dried, and incubated with 12 ng/l trypsin (Pro-
mega) in 25 mM ammonium bicarbonate for 1 h at 60 °C. Pep-
tides were purified with ZipTip C18 (Millipore), eluted with 1
l of -cyano-4-hydroxycinnamic acid (Waters), and analyzed
by mass spectrometry on a time-of-flight mass spectrometer
(Voyager-DE STR; Applied Biosystems). Data from 200 laser
shots were collected to produce a mass spectrum that was ana-
lyzed with Data explorer version 4.0.0.0 (Applied Biosystems).
Western Blotting—Proteins were separated by electrophore-
sis and transferred to polyvinylidene difluoride membranes
(Millipore). Blots were blocked with 5% nonfat dry milk in
TBS-T buffer (20 mM Tris-HCl, pH 7.4, 150 mM NaCl, and
0.05% Tween 20) for 1 h at room temperature and incubated
overnight at 4 °C with 3% BSA in TBS-T with either 2 g/ml
anti-galectin-1 or 0.2g/ml anti-S100A8 or anti-S100A9 (R&D
Systems); 5% BSA with 0.2 g/ml anti-S100A6 (R&D Systems);
and in 3% nonfat dry milk in TBS-T buffer with 0.2 g/ml anti-
transgelin (ProteinTech), 0.2 g/ml anti-hemopexin or 0.2
g/ml anti-calgranulin A/B (Santa Cruz Biotechnology). Blots
were then incubatedwith 10 ng/ml rabbit anti-goat horseradish
peroxidase (Jackson ImmunoResearch), donkey anti-rabbit
horseradish peroxidase (GE Healthcare), and goat anti-mouse
horseradish peroxidase (Jackson ImmunoResearch), respec-
tively. Finally, blots were washed with TBS-T and developed
with Immobilon Western chemiluminescent HRP substrate
(Millipore). Chemiluminescent images were taken in a Fujifilm
LAS3000 mini.
Neutrophil Isolation and Culture—Neutrophils from
Adamts12/ andAdamts12/micewere isolated fromperi-
toneal lavage as described previously (15). Cells were then
washed and levels of apoptotic neutrophils determined by flow
cytometry in aCytomics FC500 (Beckman-Coulter), as annexin
V- and Ly6G-positive cells using the anti-Ly6G antibody and
the annexinV-FITC/propidium iodide (PI) kit (APOAF-50TST
047K4115; Sigma). For co-culture with ADAMTS-12-overex-
pressing cells, human neutrophils were isolated from periph-
eral blood of healthy donors under informed consent. Briefly, 4
ml of blood was mixed with 4 ml of a sterile solution of 0.9%
NaCl. Diluted blood was then added to 4 ml of LymphoprepTM
and centrifuged for 20 min at 800 relative centrifugal force.
After separation, supernatant was removed, and the pellet con-
taining granulocytes and erythrocytes was suspended in 12 ml
of erythrocyte lysis buffer (150 mM NH4Cl, 10 mM KHCO3, 0.1
mM EDTA). After 10min, this suspension was centrifuged for 5
min at 400 relative centrifugal force; supernatant was removed,
and the remaining pellet was washed with 800l of erythrocyte
lysis buffer. The final pellet containing purified granulocytes
(mainly neutrophils) was resuspended in RPMI 1640 medium
and counted. 2  105 cells were co-cultured in 6-well plates
with control EBNA cells or EBNA cells overexpressing
ADAMTS-12 (EBNA-TS12) (7). After 15 h, neutrophils were
collected, washed, and analyzed through flow cytometry to
determine apoptosis levels using the annexin V-FITC/PI kit.
RT-PCR Analysis—Total RNA from tissue samples and cells
was isolated using TRIzol, and reverse transcription reactions
were carried out with 300 ng of RNA, using the Thermoscript
RT-PCR system (Invitrogen) with random hexamers. For anal-
ysis of human ADAMTS12 expression, 9 l of a 1:5 dilution of
cDNA was employed in quantitative PCR using the TaqMan
probe HS00917112_m1 and TaqMan Master Mix in an Abi-
Prism 7900HT (Applied Biosystems) and following the manu-
facturer’s instructions. In the case of murine Adamts12, 2 l of
cDNA was used as template for further amplification employ-
ing Platinum Taq polymerase (Invitrogen) and the specific
primers 5-CGTGGAGTCGTACATCCTCAC-3 (forward)
and 5-CCCACGGGCTCACAGTCATTT-3 (reverse), which
amplify a 441-bp fragment. PCR amplificationswere performed
under the following conditions: one cycle at 94 °C for 2min, and
35 cycles at 94 °C for 30 s, 58 °C for 30 s, and 72 °C for 30 s.
-Actin was amplified as an internal control.
Statistical Analysis—All statistical analysis were carried out
with the GraphPad Prism 5.0 software. Data are presented as
means S.E. The occurrence of significant differences between
groups was determined with the Student’s t test (for Gaussian
distributions) or theMann-Whitney test (nonparametric). Sur-
vival curves were compared using the Gehan-Breslow-Wilc-
oxon test. p values under 0.05 were considered significant
(*, p 0.05; **, p 0.01; ***, p 0.001).
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RESULTS
Adamts12 Deficiency Results in Increased Inflammation and
Higher Susceptibility to DSS-induced Colitis—Whereas no sig-
nificant differences were observed in clinical features (diarrhea
and rectal bleeding), we detected increased weight loss in
Adamts12/ mice during DSS treatment (Fig. 1A). Likewise,
significantly reduced colon length, a symptomof inflammation,
was also observed in knock-out (KO)mice comparedwithwild-
type (WT) at days 6 (mean WT  5.28  0.16; KO  4.60 
0.22) and 8 (mean WT 5.22 0.11; KO 4.75 0.12) (Fig.
1B). The degree of inflammation was also evaluated in terms of
cytokine abundance in colonic lavage.We found enhanced lev-
els of IL-1, IL-6, and G-CSF inAdamts12-deficient mice, with
these differences being significant at day 6 for IL-6 (Fig. 1C and
supplemental Fig. 1). Histological examination of colon
revealed that the extent of surface affected by ulcers was higher
FIGURE 1. Increased susceptibility of Adamts12-deficient mice to colitis. A, increased body weight reduction of Adamts12/mice during colitis. Weights
are expressed as means of individual data relative to initial body weight of each animal. B, colon length at time of sacrifice prior or during 2% DSS treatment.
C, levels of IL-6 in colonic lavage as determined by ELISA. D, microscopic images of colonic mucosa stained with hematoxylin and eosin at day 8 after DSS
treatment inmice from both genotypes. Ulcerated surface, more abundant in KO tissue, is indicated with red arrows. E, percentage of colonic surface affected
by ulcers at days 0, 3, 6, 8, and 16. F, Kaplan-Meier plot of Adamts12/ and Adamts12/ during DSS-induced colitis. Comparison of survival curves for both
genotypes using the Gehan-Breslow-Wilcoxon test revealed thatmortality was significantly higher in KO animals (p value 0.0454).G, representative images
of MPO staining in DSS-treated colons at day 8. Red arrows indicate some of the MPO-positive cells. H, quantification of MPO-positive brown cells per field in
affected mucosa at days 6 and 8 of treatment. *, p 0.05; **, p 0.01; ***, p 0.001. Results are expressed as means S.E. (error bars).
Loss of Adamts12 Impairs Inflammation
NOVEMBER 16, 2012•VOLUME 287•NUMBER 47 JOURNAL OF BIOLOGICAL CHEMISTRY 39557
 at UNIVERSIDAD DE O
VIEDO
, on January 25, 2013
w
w
w
.jbc.org
D
ow
nloaded from
 
in Adamts12/ animals, especially at day 8 (mean 52.5% in
mutant mice versus 30.6% in controls) (Fig. 1, D and E). To
study putative differences regarding mortality, we treated
another group of animals and observed that mortality was
increased in Adamts12-deficient mice compared with control
littermates (Fig. 1F). Once thesemice had recovered their initial
body weight (at day 16), they were sacrificed, and although no
apparent differences were observed at the histological level,
colons from Adamts12/ were still significantly shortened
(Fig. 1B).
Increased Inflammation inAdamts12/MiceColon Is Asso-
ciated withNeutrophil Accumulation—Examination of areas of
ulceration with an anti-MPO antibody revealed a marked
increase in neutrophil infiltration in Adamts12-deficient tissue
(Fig. 1G). Quantitative analysis confirmed a significant increase
in the number of positive cells per field (p 0.0001,
Adamts12/mean 19.38 1.49 at day 6 and 23.58 1.48 at
day 8; Adamts12/mean 9.50 1.01 at day 6 and 12.56
1.36 at day 8) (Fig. 1H). The sustained presence of neutrophils
in colon would generate a pro-inflammatory environment that
could contribute to explain the exacerbated affectation
observed in DSS-treated Adamts12/.
Several InflammationMarkers Are Elevated at the Transcrip-
tional and Proteomic Levels in the Absence of Adamts12—
mRNA profiles from affected colons at day 8 of Adamts12/
mice revealed augmented expression of several inflammation
markers. Of the28,000 genes analyzed, we selected 21 whose
expressionwas similar between genotypes when untreated (dif-
fering in 2-fold) but overexpressed 	6 or more times in
mutant animals under DSS treatment (Fig. 2). Bioinformatic
analysis to identify enrichment of functionally related genes
revealed an enrichment of genes involved in the cytokine and
cytokine-receptor interaction (p  4.2  106) and of genes
expressed during hematopoiesis, specifically in the neutrophil
lineage (p  6.63  107). This group of genes includes those
encoding several interleukins, the calgranulins S100A8 and
S100A9, and the chemokines Ccl11 or Cxcl10. Additionally,
Hdc and Aldhla3 genes necessary for histamine synthesis and
metabolism, as well as MMP genes that have also been related
to inflammation (16, 17), such as Mmp3 and Mmp13, were
increased in KO mice. Notably, IL-6, one of the overexpressed
cytokines in mutant mice and also found accumulated at the
colonic lavage of these animals (Fig. 1C), has been traditionally
considered as a marker of inflammatory bowel disease severity
(18–21). Finally, it is remarkable that few genes were found to
be down-regulated in Adamts12-deficient mice and were not
ascribable to specific functions. This is the case of LgalS6, a
galectin present in murine gastrointestinal tract and of arylac-
etamide deacetylase and hydroxysteroid dehydrogenase 13,
which encode enzymes participant in metabolic processes.
We then explored putative differences at the protein level.
For this purpose, we performed a two-dimensional DiGE com-
bined with MALDI-ToF analysis of colon samples from
Adamts12/ and Adamts12/ animals treated with DSS at
day 8. We identified several proteins, including galectin-1,
hemopexin, transgelin, S100A6, S100A8, and S100A9, accumu-
lated in KO tissues (Fig. 3A). These results were validated
through two-dimensional Western blotting (Fig. 3B). S100A8
and S100A9were also found increased at themRNA level, rein-
forcing the above results and ruling out a protein accumulation
caused by a putative absence of proteolytic processing by
Adamts-12. None of the other mentioned proteins were found
transcriptionally overexpressed. Further one-dimensional
Western blotting confirmed that S100A8, S100A9, and
hemopexin were uniformly accumulated in all KO tissues at
days 6 and 8 of treatment (no significant differences were evi-
dent at day 3) (Fig. 3C and densitometry analysis in supplemen-
tal Fig. 2, A and B). In the case of hemopexin, two-dimensional
Western blots showed that the isoforms accumulated in
Adamts12/ colons were barely or not detected in samples
from Adamts12/ animals (Fig. 3B). This finding, together
with the fact that no expression differences were found for
hemopexin at the transcriptional level, suggests that
Adamts-12 could be involved in the post-translational process-
ing of hemopexin. Finally, calprotectin, a heterodimeric com-
plex formed by combination of S100A8 and S100A9, was also
accumulated in KO tissues at day 8 (Fig. 3C, right panel).
Adamts12/ Mice Show Delayed Recovery after LPS-in-
duced Sepsis—Next, we analyzed theAdamts-12 role in amodel
of global acute inflammation, by comparing the host response
to LPS-induced sepsis. Although no significant differences
were observed regarding mortality or weight loss, we noticed
significant differences affecting different blood parameters.
Thus, we detected an increased hematocrit at day 3 and a higher
number of leukocytes at day 8 in Adamts12/mice (Fig. 4, A
and B). The enhanced hematocrit is likely due to a more severe
dehydration affecting KOmice. Likewise, one of the major fea-
tures achieved during sepsis is the increase of leukocytes in
FIGURE 2. Microarray analysis in colon from Adamts12/ and
Adamts12/ mice. Heat map represents the relative expression levels of
selected genes as determined by hybridization with GeneChip Mouse Gene
1.0 ST Arrays.
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blood. In this sense, at day 8 after LPS injection, the number of
white blood cells was significantly increased in Adamts12/
mice compared with controls (Fig. 4B). We observed that the
increment in leukocyte number at day 8 is presumably due to an
increase in the number of neutrophil granulocytes (Fig. 4C). At
day 3 after treatment, we detected changes in the percentage of
each cell type: monocytes and neutrophils weremore abundant
in Adamts12-deficient mice, whereas lymphocyte number was
reduced compared with WT animals (Fig. 4C).
We next investigated possible differences affecting the
altered molecular targets identified in colitis. To this end, we
performed Western blot analysis for hemopexin, S100A8 and
S100A9 in protein extracts from spleen and liver of LPS-treated
mice at day 8. As shown in Fig. 4D and supplemental Fig. 2, C
andD, S100A8 and S100A9were shown to be differentialmark-
ers for Adamts12/ also during sepsis.
Higher Affectation of Adamts12/ Mice Pancreas after
Cerulein Treatment—Adamts12/ and Adamts12/ mice
were challengedwith cerulein to induce pancreatitis.Mean lev-
els of pancreatic enzymes (lipase and amylase) were higher in
mutant mice compared with WT animals, although no signifi-
cant differences derived from statistical analysis (levels of
serum amylase were 26.45 2.18 inAdamts12/ and 29.22
2.18 units/liter in Adamts12/ mice; lipase levels were
789.0  83.2 and 941.1  84.5 units/liter, respectively). How-
ever, we found significantly increased edema among pancreatic
FIGURE3. Identificationofdifferentialproteins incolon fromDSS-treatedAdamts12/andAdamts12/mice.A, representativeDiGE imagewith tissue
extracts from Adamts12/ (CyDye 3, green) and Adamts12/ (CyDye 5, red) mice. Some of the differential proteins are indicated. B, differentially produced
proteins identified by MALDI-ToF confirmed by two-dimensional Western blotting. In each blot, uni-dimensional experiments of both Adamts12/ and
Adamts12/ tissues are identifiable on the right.-Actinwas used as a loading control.C,Westernblots detectingprotein levels of those candidates identified
in DiGE analysis in three representative animals per genotype and time point. S100A8, S100A9, calprotectin, and hemopexinwere found to be accumulated in
the absence of Adamts-12 at days 6 and 8 in two different sets of three Adamts12/mice compared with three Adamts12/ animals. -Actin was used as a
loading control.
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acini of specimens from Adamts12/ mice (Fig. 5A). The
mean interacinar distance in treated mice was 5.03 0.23 m
in KO animals and 4.06  0.21 m in WT mice (Fig. 5A).
Finally, we examined levels of S100A8, S100A9, and hemopexin
in pancreas of pancreatitis-induced mice. We found an accu-
mulation of hemopexin in Adamts12/ tissue equivalent to
that defined for colitis (Fig. 5B and supplemental Fig. 2E),
although no evident differences were detected for S100A8 and
S100A9.
Adamts-12 Induces Neutrophil Apoptosis—To better under-
stand the mechanism underlying the observed effects in
Adamts12/mice,we explored the putative link betweenneu-
trophil accumulation and the absence of this protease. In this
regard, it is well known that once neutrophil activities during
acute response have been completed, these cells die by cell pro-
grammeddeath andundergomacrophage clearance (22). Based
on these considerations, we askedwhether Adamts-12 could be
necessary for appropriate neutrophil apoptosis. We isolated
peritoneal neutrophils from Adamts12/ and Adamts12/
animals and analyzed their levels of apoptosis, finding a
marked reduction in neutrophil apoptosis in the absence of
Adamts-12: 16.79%  1.20 of neutrophils from WT animals
were annexin V-positive versus 10.49%  1.01 from mutant
mice (Fig. 6A).
We then asked whether this effect on apoptosis could also be
detected in vitro. To this end, we isolated nonactivated neutro-
phils from blood of healthy human donors and co-cultured
them for 15 h with control EBNA cells or EBNA cells overex-
pressing ADAMTS-12. We found that in the presence of
ADAMTS-12, the percentage of apoptotic cells raised from
56.7% to 68.4% (Fig. 6B). Frompreviousworks (12, 13), we know
that ADAMTS12 is expressed by humanmyofibroblasts, which
are one of the predominant cells in stroma in proinflammatory
environments such as wound healing and cancer. In themodels
FIGURE 4. Increased susceptibility to LPS-induced sepsis in Adamts12/mice. A, variation in hematocrit during treatment. Mice lacking Adamts12 show
an increased hematocrit at day 3 after LPS injection, likely as an effect of more severe dehydration, comparedwith wild-type animals. B, levels of leukocytes in
peripheral blood after LPS injection. At day 8 after treatment, Adamts12/ mice show an enhanced number of leukocytes. C, composition of leukocyte
populations in peripheral blood after LPS treatment. At day 3, an evident deviation in leukocyte populations was observed in Adamts12/ mice, which
exhibited reduced lymphocytes and increased monocytes and granulocytes compared with control animals. At day 8, the number of neutrophils was still
increased inmice lacking themetalloprotease.D,Westernblot against S100A8andS100A9 in spleens and livers fromLPS-treatedmice. S100A8andS100A9are
elevated in tissues of Adamts12/mice 8 days after induction of sepsis. *, p 0.05; **, p 0.01; ***, p 0.001.
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studied herein, ADAMTS-12 could be controlling neutrophil
apoptosis through cell components of stroma, like activated fibro-
blasts. Nevertheless, we also asked whether neutrophils them-
selves could be expressing this metalloprotease. For this purpose,
we performed RT-PCR and quantitative RT-PCR to analyze
ADAMTS12 expression in neutrophils from murine and human
origin, respectively. Whereas ADAMTS12 expression in lympho-
cytes was minimal, we detected significant expression in human
(up to 7000-fold overexpression comparedwith lymphocytes) and
murine neutrophils (Fig. 6C and data not shown).
DISCUSSION
The current view of proteases as modulators of precise pro-
teolytic processing events is far away from the traditional one in
which they were conceived as mere degradative enzymes in
charge of protein catabolism (23, 24). Nowadays,560 human
FIGURE 5. Increased affection ofAdamts12/mice after cerulein-inducedpancreatitis.A,Adamts12-deficient tissues aremore affected by edemaduring
pancreatitis.Microscopic images showaffectedpancreas stainedwith hematoxylin and eosin. Edema, one of themain indicators of pancreatitis, was increased
in the interacinar spaces (indicatedwith red arrows) ofAdamts12/mice after treatmentwith cerulein.B, increased levels of hemopexin in pancreatitis ofmice
deficient in Adamts12. ***, p 0.001.
FIGURE 6.ADAMTS-12 is expressed inneutrophils and induces their apoptosis.A, apoptosis levels of peritoneal neutrophils fromAdamts12/ (n 7) and
Adamts12/ (n 6)mice after casein induction. B, percentage of live and apoptotic humanneutrophils after co-culturewith EBNA-TS12 or EBNA-control. Live
cells are annexin V- and PI-negative; pre-apoptotic cells are annexin V-positive, PI-negative; apoptotic cells are annexin V- and PI-positive; and necrotic
cells are annexin V-negative and PI-positive. C, RT-PCR showing murine Adamts12 expression in cDNA from WT and KO lymphocytes and neutrophils.
**, p  0.01.
Loss of Adamts12 Impairs Inflammation
NOVEMBER 16, 2012•VOLUME 287•NUMBER 47 JOURNAL OF BIOLOGICAL CHEMISTRY 39561
 at UNIVERSIDAD DE O
VIEDO
, on January 25, 2013
w
w
w
.jbc.org
D
ow
nloaded from
 
proteases have been identified (25). These proteases establish
intimate interactions with very specific substrates and are
strictly regulated over time and space through control of their
expression, activity, and location. As a result, most proteases
perform very specific proteolytic cleavages on a number of dif-
ferent substrates and influence multiple biological processes
(1).Hence, predicting the phenotype of animalmodels deficient
in a certain protease is very difficult and often offers unexpected
findings. To date, several mouse models lacking ADAMTSs
have been generated with a heterogeneous spectrum of pheno-
types including those found in Adamts4- and Adamts5-defi-
cient mice, which are protected from osteoarthritis (26), and in
Adamts13-deficient mice, which show increased inflammation
due to enhanced extravasation of neutrophils (27).
In the present work, we have found that loss-of-function of
Adamts-12 enhances mouse susceptibility to inflammatory
processes. This phenotype was not limited to a certain tissue as
it was a common phenomenon affecting several organs. Thus,
mice lacking Adamts12 exhibited an increased damage subse-
quent to inflammation in colon and pancreas and during endo-
toxic shock. Particularly, Adamts12/ mice subjected to
induction of experimental colitis showed a more pronounced
loss of weight, colon shortening, and epithelial ulceration. Sim-
ilar results were observed during pancreatitis, as histopatholog-
ical analysis of pancreas revealed a more pronounced edema in
tissues from mutant mice. Additionally, induction of systemic
sepsis highlighted the higher inflammatory response taking
place inAdamts12-deficientmice. Further gene expression and
proteomic studies confirmed and extended these differences, as
most differential RNAs and proteins identified in these mutant
mice are indicators of increased inflammation. These were the
cases with the pro-inflammatory cytokines IL-6, IL-11, or CCL-
11, and the calcium-binding proteins S100A8 and S100A9,
important amplifiers and markers of acute and chronic inflam-
mation (28), which were increased at both RNA and protein
level in Adamts12-deficient mice. The latter two proteins form
the heterodimer calprotectin, currently used as a diagnostic
indicator for inflammatory bowel diseases when present in
feces, and which was also found accumulated in colons from
Adamts12/ mice exposed to DSS. Taken collectively, all of
these observations indicate that Adamts-12 is necessary for a
normal inflammatory response in mice.
We also found that themore severe inflammatory symptoms
observed in Adamts12-deficient mice were accompanied by
neutrophilia in the affected tissues, which provided us a first
clue to initiate the search for the mechanism underlying the
phenotypic and molecular differences present in these mutant
mice. In normal conditions, and immediately after a harmful
stimulus, neutrophils migrate toward the affected tissue and
contribute to the development of an immune response. Thus,
these cells produce pro-inflammatory cytokines that attract
other inflammatory cells and amplify the response as well as
release toxic substances aimed at eliminating pathogens. Nev-
ertheless, when this delicate balance is altered and excessive
neutrophils are present, they can promote chronic inflamma-
tion and directly cause damage to the host tissue (29). Nor-
mally, after neutrophils exert their function in the acute phase
response, they suffer massive apoptosis and are phagocytosed
by macrophages (22). On this basis, we hypothesized that a
defect in apoptosis in the absence of Adamts-12 could be
responsible for the increased number of neutrophils. To test
this possibility, we analyzed changes in apoptotic death in neu-
trophils from human and murine origin, with the finding that
the presence of this metalloprotease triggered an increment
in their apoptosis. In this regard, previousworks have described
the ability of proteins containing thrombospondin type-1
repeats to interact with surface proteins such as CD36 and
CD47 (30, 31), that can modulate neutrophil death and clear-
ance (32, 33). Hence, it is conceivable a model in which
ADAMTS-12 could participate in similar protein interactions
through its thrombospondin domains. Alternatively, we have
found that some hemopexin isoforms were accumulated in
Adamts12-deficient mice (Fig. 3, A and B), which may suggest
an implication of this metalloprotease on hemopexin process-
ing. If this were the case, the absence ofAdamts12 could lead to
an altered function of hemopexin, which is mainly involved in
sequestering the extracellular free heme and in its recovery in
liver (34). Free heme is released during several types of cell
damage, causing oxidative effects and promoting inflamma-
tion. Indeed, it has been proven that heme is able to delay spon-
taneous apoptosis of human neutrophils (35). Additionally, two
of the cytokines found increased in Adamts12 KO mice, IL-6
and G-CSF, have also been related to neutrophil apoptosis and
survival. G-CSF has been described as a potent promoter of
neutrophil durability (36) and may be acting in this context as
one of the mediators for neutrophil death inhibition. Con-
versely, IL-6 allows the successful transition from innate to
adaptive response by limiting neutrophil recruitment (37), and
its increased levels inAdamts12-deficient mice could be part of
a homeostatic response to the excessive neutrophilia, otherwise
inefficient due to the impaired apoptosis. Finally, ADAMTS-12
might be involved in other processes apart from neutrophil
apoptosis, such as neovascularization or matrix remodeling,
which contribute to normal healing of ulcers in colitis. All of
these results are preliminary but relevant evidences of the
molecularmechanisms bywhichADAMTS-12 exerts its role in
inflammation. Nevertheless, all of the proposed hypothesis are
conjectural and may be clarified in future experiments.
In summary, in this work we provide evidence on how
Adamts12 deficiency is responsible for increased inflammation
inmice and reduced apoptosis of neutrophils. Furthermore, we
know from previous studies that Adamts-12 is also implicated
in angiogenesis, apoptosis of tumor cells and modification of
the extracellularmatrix (7, 12, 14). Therefore, albeit Adamts-12
is not essential for life, probably due to functional compensa-
tion by other ADAMTSs, the contribution of this enzyme to a
variety of inflammatory processes highlights its relevance in the
context of the large and growing complexity of proteolytic sys-
tems operating in life and disease.
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